198 related articles for article (PubMed ID: 36730637)
21. Circ_0000471 suppresses the progression of ovarian cancer through mediating mir-135b-5p/dusp5 axis.
Yu S; Yu M; Chen J; Tang H; Gong W; Tan H
Am J Reprod Immunol; 2023 Apr; 89(4):e13651. PubMed ID: 36369900
[TBL] [Abstract][Full Text] [Related]
22. Circ_0030998 Restrains Cisplatin Resistance Through Mediating miR-1323/PDCD4 Axis in Non-small Cell Lung Cancer.
Zhu C; Jiang X; Xiao H; Guan J
Biochem Genet; 2022 Dec; 60(6):2434-2454. PubMed ID: 35460386
[TBL] [Abstract][Full Text] [Related]
23. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP.
Liu R; Zhang Y; Sun P; Wang C
Open Biol; 2020 Apr; 10(4):190173. PubMed ID: 32343928
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.
Liu X; Yin Z; Wu Y; Zhan Q; Huang H; Fan J
Bioengineered; 2022 Feb; 13(2):3739-3750. PubMed ID: 35081867
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis.
Sun Y; Ma J; Lin J; Sun D; Song P; Shi L; Li H; Wang R; Wang Z; Liu S
Anticancer Drugs; 2021 Oct; 32(9):950-961. PubMed ID: 34016832
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300.
Ding L; Li L; Tang Z
Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026
[TBL] [Abstract][Full Text] [Related]
27. Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer.
Yin Y; Li J; Rong J; Zhang B; Wang X; Han H
Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):261-274. PubMed ID: 35179434
[TBL] [Abstract][Full Text] [Related]
28. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
Jin Y; Wang H
J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
Pang J; Ye L; Zhao D; Zhao D; Chen Q
Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
[TBL] [Abstract][Full Text] [Related]
30. Circ_0001402 knockdown suppresses the chemoresistance and development of DDP-resistant cutaneous squamous cell carcinoma cells by functioning as a ceRNA for miR-625-5p.
Li M; Luo M; Liu P; Wang R; Jing H
Exp Dermatol; 2023 Apr; 32(4):529-541. PubMed ID: 36635223
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
Wei S; Qi L; Wang L
Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
[TBL] [Abstract][Full Text] [Related]
32. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis.
Hao D; Li Y; Shi J; Jiang J
Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322
[TBL] [Abstract][Full Text] [Related]
33. Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer.
Chen J; Wu S; Wang J; Sha Y; Ji Y
Reprod Sci; 2022 Aug; 29(8):2236-2250. PubMed ID: 35075616
[TBL] [Abstract][Full Text] [Related]
34. Circ-SKA3 Enhances Doxorubicin Toxicity in AC16 Cells Through miR-1303/TLR4 Axis.
Li B; Cai X; Wang Y; Zhu H; Zhang P; Jiang P; Yang X; Sun J; Hong L; Shao L
Int Heart J; 2021 Sep; 62(5):1112-1123. PubMed ID: 34544967
[TBL] [Abstract][Full Text] [Related]
35. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.
Yu N; Gong H; Chen W; Peng W
Thorac Cancer; 2023 Jun; 14(16):1467-1476. PubMed ID: 37105934
[TBL] [Abstract][Full Text] [Related]
36. Circ_0061140 Contributes to the Malignant Progression in Ovarian Cancer Cells by Mediating the RAB1A Level Through Sponging miR-361-5p.
Zhang Y; Di Q; Chen J; Chang M; Ma Y; Yu J
Biochem Genet; 2022 Dec; 60(6):1946-1962. PubMed ID: 35181843
[TBL] [Abstract][Full Text] [Related]
37. Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis.
Chen Z; Xu Z; Wang Q; Wang L; Zhang H; Wang W; Zhao H; Guo Y; Cui J
Cell Cycle; 2023 Oct; 22(20):2211-2228. PubMed ID: 37974391
[TBL] [Abstract][Full Text] [Related]
38. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
[TBL] [Abstract][Full Text] [Related]
39. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
40. Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB.
Lin D; Wang Y; Lei L; Lin C
Autoimmunity; 2022 Mar; 55(2):127-135. PubMed ID: 35001739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]